These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 34724703)

  • 1. Practice patterns and real-life outcomes for patients with acute promyelocytic leukemia in the United States.
    Bewersdorf JP; Prozora S; Podoltsev NA; Shallis RM; Huntington SF; Neparidze N; Wang R; Zeidan AM; Davidoff AJ
    Blood Adv; 2022 Jan; 6(2):376-385. PubMed ID: 34724703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome of Adolescents and Young Adults Compared With Pediatric Patients With Acute Myeloid and Promyelocytic Leukemia.
    Nasir SS; Giri S; Nunnery S; Martin MG
    Clin Lymphoma Myeloma Leuk; 2017 Feb; 17(2):126-132.e1. PubMed ID: 27836483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of body mass index on incidence and prognosis of acute myeloid leukemia and acute promyelocytic leukemia: A meta-analysis.
    Li S; Chen L; Jin W; Ma X; Ma Y; Dong F; Zhu H; Li J; Wang K
    Sci Rep; 2017 Dec; 7(1):17998. PubMed ID: 29269861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A convolutional neural network-based, quantitative complete blood count scattergram-mapping framework promptly screens acute promyelocytic leukemia with high sensitivity.
    Liao H; Xu Y; Meng Q; Mao Z; Qiao Y; Liu Y; Zheng Q
    Cancer; 2023 Oct; 129(19):2986-2998. PubMed ID: 37254628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disparity in Utilization of Multiagent Therapy for Acute Promyelocytic Leukemia in the United States.
    Dhakal P; Lyden E; Joshi U; Pyakuryal A; Gundabolu K; Zeidan AM; Loh KP; Fisher AL; Bhatt VR
    Clin Lymphoma Myeloma Leuk; 2022 May; 22(5):319-325. PubMed ID: 34852977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing the epidemiology, clinical characteristics and prognostic factors of acute myeloid leukemia with and without acute promyelocytic leukemia.
    Kamath GR; Tremblay D; Coltoff A; Caro J; Lancman G; Bhalla S; Najfeld V; Mascarenhas J; Taioli E
    Carcinogenesis; 2019 Jul; 40(5):651-660. PubMed ID: 30715157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High frequency of acute promyelocytic leukemia among Latinos with acute myeloid leukemia.
    Douer D; Preston-Martin S; Chang E; Nichols PW; Watkins KJ; Levine AM
    Blood; 1996 Jan; 87(1):308-13. PubMed ID: 8547657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuing high early death rate in acute promyelocytic leukemia: a population-based report from the Swedish Adult Acute Leukemia Registry.
    Lehmann S; Ravn A; Carlsson L; Antunovic P; Deneberg S; Möllgård L; Derolf AR; Stockelberg D; Tidefelt U; Wahlin A; Wennström L; Höglund M; Juliusson G
    Leukemia; 2011 Jul; 25(7):1128-34. PubMed ID: 21502956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival and risk factors for mortality in pediatric patients with acute myeloid leukemia in a single reference center in low-middle-income country.
    Lins MM; Mello MJG; Ribeiro RC; De Camargo B; de Fátima Pessoa Militão de Albuquerque M; Thuler LCS
    Ann Hematol; 2019 Jun; 98(6):1403-1411. PubMed ID: 30915498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global characteristics of childhood acute promyelocytic leukemia.
    Zhang L; Samad A; Pombo-de-Oliveira MS; Scelo G; Smith MT; Feusner J; Wiemels JL; Metayer C
    Blood Rev; 2015 Mar; 29(2):101-25. PubMed ID: 25445717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Types, Clinical Features, and Survival Outcomes of Patients with Acute Myeloid Leukemia in Thailand: A 3-Year Prospective Multicenter Study from the Thai Acute Leukemia Study Group (TALSG).
    Wanitpongpun C; Utchariyaprasit E; Owattanapanich W; Tantiworawit A; Rattarittamrong E; Niparuck P; Puavilai T; Julamanee J; Saelue P; Chanswangphuwana C; Polprasert C; Nakhakes C; Limvorapitak W; Kanitsap N; Prayongratana K; Sriswasdi C
    Clin Lymphoma Myeloma Leuk; 2021 Jul; 21(7):e635-e643. PubMed ID: 33926829
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Zhou J; Gou H; Zhang L; Wang X; Ye Y; Lu X; Ying B
    DNA Cell Biol; 2019 Nov; 38(11):1374-1386. PubMed ID: 31599655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between increased body mass index and a diagnosis of acute promyelocytic leukemia in patients with acute myeloid leukemia.
    Estey E; Thall P; Kantarjian H; Pierce S; Kornblau S; Keating M
    Leukemia; 1997 Oct; 11(10):1661-4. PubMed ID: 9324286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving Outcomes of Acute Promyelocytic Leukemia in the Current Era: Analysis of the SEER Database.
    Guru Murthy GS; Szabo A; Michaelis L; Carlson KS; Runaas L; Abedin S; Atallah E
    J Natl Compr Canc Netw; 2020 Feb; 18(2):169-175. PubMed ID: 32023530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute promyelocytic leukemia is a distinct subset of acute myelocytic leukemia with unique clinicopathologic characteristics including longer duration of relapse free survival: experience in 13 cases.
    Lee KH; Kim DH; Lee JS; Suh CW; Kim SW; Kim SB; Lee JH; Doh BS; Chi HS; Lee MS
    J Korean Med Sci; 1994 Dec; 9(6):437-43. PubMed ID: 7786438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Addressing the room for improvement in management of acute promyelocytic leukemia.
    Nørgaard JM; Friis LS; Kristensen JS; Severinsen MT; Mølle I; Marcher CW; Møller P; Schoellkopf C; Nielsen OJ; Preiss BS; Andersen MK; Kjeldsen E; Medeiros BC; Østgård LSG;
    Eur J Haematol; 2019 Jun; 102(6):479-485. PubMed ID: 30887583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early mortality and overall survival in acute promyelocytic leukemia: do real-world data match results of the clinical trials?
    Dhakal P; Lyden E; Rajasurya V; Zeidan AM; Chaulagain C; Gundabolu K; Bhatt VR
    Leuk Lymphoma; 2021 Aug; 62(8):1949-1957. PubMed ID: 33711907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement of Early Death in Acute Promyelocytic Leukemia: A Population-Based Analysis.
    Li G; Wu J; Li R; Pan Y; Ma W; Xu J; Nan M; Hou L
    Clin Lymphoma Myeloma Leuk; 2023 Feb; 23(2):e78-e84. PubMed ID: 36567214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stepwise discriminant function analysis for rapid identification of acute promyelocytic leukemia from acute myeloid leukemia with multiparameter flow cytometry.
    Chen Z; Li Y; Tong Y; Gao Q; Mao X; Zhang W; Xia Z; Fu C
    Int J Hematol; 2016 Mar; 103(3):306-15. PubMed ID: 26759321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute promyelocytic leukaemia is highly frequent among acute myeloid leukaemias in Brazil: a hospital-based cancer registry study from 2001 to 2012.
    Thuler LCS; Pombo-de-Oliveira MS
    Ann Hematol; 2017 Mar; 96(3):355-362. PubMed ID: 27752823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.